SuperworthPrecision Biosciences market cap DTIL
Share price times shares outstanding: what the whole company sells for, since 2019.
- Today, Oct 23, 2026
- $183.3M
- Highest close in our data
- $998.5M
- Dec 2019
Precision Biosciences is worth $183.3M at the close on Oct 23, 2026, at $6.64 a share.
That is up 131% over the last year and down 68% over five years.
Its highest close in our data was $998.5M in Dec 2019.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $183.3M | $50.2M | $244.3M | +227% |
| 2025 | $56.1M | $36.1M | $96.2M | +57% |
| 2024 | $35.7M | $35.7M | $98.7M | −18% |
| 2023 | $43.4M | $33M | $152M | −67% |
| 2022 | $132M | $78.3M | $398.6M | −71% |
| 2021 | $449.7M | $449.7M | $803.7M | +3% |
| 2020 | $437.7M | $239.5M | $746.6M | −39% |
| 2019 | $713.6M | $323.5M | $998.5M | n/a |
Against its peers
Companies in Healthcare nearest Precision Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| DTILPrecision Biosciences | $183.3M |
| PDEXPro DEX | $199.3M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| INFUInfuSystem | $277.6M |
| KEQUKewaunee Scientific | $94.9M |
| ICCCImmucell | $93.1M |
| VMDViemed Healthcare | $373.3M |
| EMBCEmbecta | $380.2M |
| Peer median | $217.2M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Precision Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.